000 01336nam##2200289za#4500
0019.573959
003CaOODSP
00520210624183942
007cr |||||||||||
008150406|2001||||xxc|||||o    f|0| 0 eng|d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH42-2/67-20-2000E-PDF
1101 |aCanada.|bHealth Canada. |bTherapeutic Products Programme.
24510|aQuality of biotechnological products : |h[electronic resource]|bstability testing of biotechnological / biological products
260 |aOttawa - Ontario : |bHealth Canada. |cJanuary 5, 2001, c2000.
300 |a17p.|bglossary
4901 |aGuidance for industry|vICH Topic Q5C
500 |aThe catalogue number (H42-2/67-20-2000E) and ISBN (0-662-29196-4) for the print edition have been incorrectly copied in this electronic publication.
590 |a12-21-Supp|b2012-05-18
69007|aBiotechnology|2gcpds
69007|aBiochemical products|2gcpds
69007|aTesting|2gcpds
77508|tQualité des produits issus de la biotechnologie : |w(CaOODSP)9.603928
7760#|tQuality of biotechnological products : |w(CaOODSP)9.615263
830#0|aGuidance for industry ;|vICH Topic Q5C|w(CaOODSP)9.506921
85640|ahttp://publications.gc.ca|qPDF|s48 KB|uhttps://publications.gc.ca/collections/Collection/H42-2-67-20-2000E.pdf|yICH Topic Q5C